PD-L1-IN-5
PD-L1-IN-5 (X22) is an orally active PD-L1 inhibitor, with the IC50 value of 785.6 nM. PD-L1-IN-5 has anti-tumor activity in vivo[1].
Product Specifications
CAS Number
[2597056-85-2]
UNSPSC
12352005
Target
PD-1/PD-L1
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pd-l1-in-5.html
Solubility
10 mM in DMSO
Smiles
OC1CCN(CCCOC2=CC=CC(C3=CC=CC(COC4=C(Cl)C=C(CN[C@@H](C(OCC)=O)CO)C(OCC5=CC6=NON=C6C=C5)=C4)=C3F)=C2)CC1
Molecular Formula
C40H44ClFN4O8
Molecular Weight
763.25
References & Citations
[1]Liu L, et al. Discovery of Novel PD-L1 Small-Molecular Inhibitors with Potent In Vivo Anti-tumor Immune Activity. J Med Chem. 2024 Mar 28;67 (6) :4977-4997.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15337311 1 Vial
Lentiviral human TMEM63B shRNA (UAS) - Lentiviral human TMEM63B shRNA (UAS, RFP) (100)
Ask
View Details MR221533L4V 200 µL
Gm4133 (NM_001167158) Mouse Tagged ORF Clone Lentiviral Particle
Ask
View Details 